These results contrast with those reported by Radmanesh et al., who published that the same c.783delG mutation of the APOBEC3B gene confers an increased risk of unselected breast cancer by 2.3 fold (95% CI 1.04–5.03, p = 0.04) and early onset breast cancer risk (below age of 50) by 3.2 fold (95% CI 1.37; 7.56, p = 0.007) in Belarus, Russia, Germany, and Iran [62]. This evidence concerns the gene APOBEC3B and breast cancer.